Sep 23, 2026 7 0
Uploaded by Cart
Favorite
Share
More Options
12
Phase 1/2 study of pegenzileukin, a pegylated recombinant non-alpha IL-2, with cemiplimab for the treatment of advanced unresectable or metastatic skin cancers_Page 1

Open in WPS to view all 12 pages